Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Its the first such drug approved for weight management since 2014 and is to be used in conjunction with a reduced-calorie diet and regular exercise
AHK-Cu's Research Base AHK-Cu's research is younger and smaller
A second drug in this line is under FDA review and could enter the market soon, and many others are being developed or already undergoing clinical trials
Requests to access these datasets should be directed to Ming-Hsien Tsai, [email protected]
Wegovy is also anticipated to be a more affordable alternative to resmetirom (Rezdiffra) from Madrigal Pharmaceuticals
Confirm whether any current medications, health conditions, pregnancy status, or family medical history may affect your eligibility - ask your assigned provider during intake
